However, to exclude the effects of CSCs, patients in the C1 group also had a higher risk to develop delayed distant metastasis during 5–7 years post tumor resection than those with <2% of CD44+/CD24- CSCs and < 19.5% of CD44-/CD24- tumor cells (the C0 group, Figure 1E). Here, CD44 is linked to neoplasm.